Added to YB: 2025-07-10
Pitch date: 2025-05-22
CTKB [bullish]
Cytek Biosciences, Inc.
+124.48%
current return
Author Info
No bio for this author
Company Info
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications.
Market Cap
$690.2M
Pitch Price
$2.41
Price Target
8.34 (+54%)
Dividend
N/A
EV/EBITDA
-12.81
P/E
-8.44
EV/Sales
2.20
Sector
Life Sciences Tools and Services
Category
growth
Cytek Biosciences, Inc. - $CTKB
CTKB: Best-in-class flow cytometry tech with $265M net cash (70% of market cap). Trades at <0.25x EV/sales despite 58% gross margins & profitability. $200M rev (2025e), growing 30% recurring revenue stream. Launching clinical platform & high-end imaging model. Major downside protection at current valuation with M&A optionality. PT: $8.34 (2028).
Read full article (4 min)